Background: Cervical cancer represents a major health problem. It is associated with the carriage of some types of high-risk papillomas. In Burkina, data on the prevalence and spectrum of genital papilloma infection in women living with HIV are poorly available.
Objective: To study human oncogenic genital papillomavirus infection in women living with HIV.
Methodology: This was a descriptive and analytical cross-sectional study which took place at CHU B between August 2021-February 2023. It concerned patients living with HIV in whom the search for Human Papillomavirus (HPV) on cervical cells and HIV viral load and CD4 lymphocyte counts were carried out. The Ceiphed GeneXpert® and Cobas® 4800 platforms were used. CD4 quantification was done using the BD FACSCount™ system.
Results: Out of a total of 403 HIV-positive patients, papillomavirus infection was found in 130 (32.3%). Genotypes 16 and 18 represented 33.1% and 15.4%, respectively. Risk factors for HPV infection were a CD4 count

Papillomavirus; Precancerous Lesions; Women; HIV; CHU-B